nodes	percent_of_prediction	percent_of_DWPC	metapath
Esmolol—Hypertensive crisis—Vandetanib—thyroid cancer	0.0577	0.0582	CcSEcCtD
Esmolol—Hypertensive crisis—Sorafenib—thyroid cancer	0.0389	0.0393	CcSEcCtD
Esmolol—Electrocardiogram ST segment depression—Epirubicin—thyroid cancer	0.0176	0.0177	CcSEcCtD
Esmolol—Respiratory failure—Vandetanib—thyroid cancer	0.0163	0.0165	CcSEcCtD
Esmolol—Electrocardiogram ST segment depression—Doxorubicin—thyroid cancer	0.0163	0.0164	CcSEcCtD
Esmolol—Pleural effusion—Sorafenib—thyroid cancer	0.0141	0.0142	CcSEcCtD
Esmolol—Myocardial ischaemia—Sorafenib—thyroid cancer	0.0134	0.0136	CcSEcCtD
Esmolol—Dermatitis bullous—Vandetanib—thyroid cancer	0.0122	0.0123	CcSEcCtD
Esmolol—Cardiac failure—Vandetanib—thyroid cancer	0.0119	0.012	CcSEcCtD
Esmolol—Skin necrosis—Epirubicin—thyroid cancer	0.0114	0.0115	CcSEcCtD
Esmolol—Cardiac arrest—Vandetanib—thyroid cancer	0.0111	0.0112	CcSEcCtD
Esmolol—Supraventricular extrasystoles—Epirubicin—thyroid cancer	0.0107	0.0108	CcSEcCtD
Esmolol—Skin necrosis—Doxorubicin—thyroid cancer	0.0106	0.0107	CcSEcCtD
Esmolol—Nasopharyngitis—Vandetanib—thyroid cancer	0.0104	0.0105	CcSEcCtD
Esmolol—Skin exfoliation—Sorafenib—thyroid cancer	0.0103	0.0104	CcSEcCtD
Esmolol—Neuropathy—Sorafenib—thyroid cancer	0.0101	0.0102	CcSEcCtD
Esmolol—Supraventricular extrasystoles—Doxorubicin—thyroid cancer	0.00991	0.01	CcSEcCtD
Esmolol—Bronchospasm—Vandetanib—thyroid cancer	0.00988	0.00997	CcSEcCtD
Esmolol—Dysuria—Vandetanib—thyroid cancer	0.00939	0.00948	CcSEcCtD
Esmolol—Cardiac failure congestive—Sorafenib—thyroid cancer	0.00864	0.00873	CcSEcCtD
Esmolol—Bradycardia—Vandetanib—thyroid cancer	0.00818	0.00826	CcSEcCtD
Esmolol—Cardiac failure—Sorafenib—thyroid cancer	0.00803	0.00811	CcSEcCtD
Esmolol—Pneumothorax—Epirubicin—thyroid cancer	0.00802	0.0081	CcSEcCtD
Esmolol—Urinary tract disorder—Vandetanib—thyroid cancer	0.00794	0.00801	CcSEcCtD
Esmolol—Urethral disorder—Vandetanib—thyroid cancer	0.00788	0.00796	CcSEcCtD
Esmolol—Visual impairment—Vandetanib—thyroid cancer	0.00775	0.00782	CcSEcCtD
Esmolol—Cardiac disorder—Vandetanib—thyroid cancer	0.00746	0.00753	CcSEcCtD
Esmolol—Pneumothorax—Doxorubicin—thyroid cancer	0.00742	0.00749	CcSEcCtD
Esmolol—Angiopathy—Vandetanib—thyroid cancer	0.00729	0.00736	CcSEcCtD
Esmolol—Mental disorder—Vandetanib—thyroid cancer	0.00704	0.00711	CcSEcCtD
Esmolol—Nasopharyngitis—Sorafenib—thyroid cancer	0.00701	0.00708	CcSEcCtD
Esmolol—Dysgeusia—Vandetanib—thyroid cancer	0.00685	0.00692	CcSEcCtD
Esmolol—Abdominal discomfort—Sorafenib—thyroid cancer	0.0065	0.00656	CcSEcCtD
Esmolol—Psoriasis—Epirubicin—thyroid cancer	0.00635	0.00641	CcSEcCtD
Esmolol—Loss of consciousness—Vandetanib—thyroid cancer	0.00615	0.00621	CcSEcCtD
Esmolol—Convulsion—Vandetanib—thyroid cancer	0.00606	0.00612	CcSEcCtD
Esmolol—Chest pain—Vandetanib—thyroid cancer	0.00596	0.00601	CcSEcCtD
Esmolol—Acute coronary syndrome—Sorafenib—thyroid cancer	0.00596	0.00601	CcSEcCtD
Esmolol—Anxiety—Vandetanib—thyroid cancer	0.00594	0.00599	CcSEcCtD
Esmolol—Myocardial infarction—Sorafenib—thyroid cancer	0.00592	0.00598	CcSEcCtD
Esmolol—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00592	0.00598	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00592	0.00597	CcSEcCtD
Esmolol—Psoriasis—Doxorubicin—thyroid cancer	0.00588	0.00593	CcSEcCtD
Esmolol—Dry mouth—Vandetanib—thyroid cancer	0.00583	0.00588	CcSEcCtD
Esmolol—Oedema—Vandetanib—thyroid cancer	0.00571	0.00577	CcSEcCtD
Esmolol—Nervous system disorder—Vandetanib—thyroid cancer	0.0056	0.00565	CcSEcCtD
Esmolol—Skin disorder—Vandetanib—thyroid cancer	0.00555	0.0056	CcSEcCtD
Esmolol—Blister—Epirubicin—thyroid cancer	0.00554	0.00559	CcSEcCtD
Esmolol—Urinary tract disorder—Sorafenib—thyroid cancer	0.00536	0.00541	CcSEcCtD
Esmolol—Urethral disorder—Sorafenib—thyroid cancer	0.00532	0.00537	CcSEcCtD
Esmolol—Pleural effusion—Epirubicin—thyroid cancer	0.00521	0.00526	CcSEcCtD
Esmolol—Paraesthesia—Vandetanib—thyroid cancer	0.00513	0.00518	CcSEcCtD
Esmolol—Blister—Doxorubicin—thyroid cancer	0.00512	0.00517	CcSEcCtD
Esmolol—Dyspnoea—Vandetanib—thyroid cancer	0.00509	0.00514	CcSEcCtD
Esmolol—Flushing—Sorafenib—thyroid cancer	0.00503	0.00508	CcSEcCtD
Esmolol—Cardiac disorder—Sorafenib—thyroid cancer	0.00503	0.00508	CcSEcCtD
Esmolol—Dyspepsia—Vandetanib—thyroid cancer	0.00503	0.00508	CcSEcCtD
Esmolol—Decreased appetite—Vandetanib—thyroid cancer	0.00497	0.00501	CcSEcCtD
Esmolol—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00493	0.00498	CcSEcCtD
Esmolol—Fatigue—Vandetanib—thyroid cancer	0.00492	0.00497	CcSEcCtD
Esmolol—Angiopathy—Sorafenib—thyroid cancer	0.00492	0.00497	CcSEcCtD
Esmolol—Rigors—Epirubicin—thyroid cancer	0.00489	0.00493	CcSEcCtD
Esmolol—Pain—Vandetanib—thyroid cancer	0.00488	0.00493	CcSEcCtD
Esmolol—Constipation—Vandetanib—thyroid cancer	0.00488	0.00493	CcSEcCtD
Esmolol—Pleural effusion—Doxorubicin—thyroid cancer	0.00482	0.00487	CcSEcCtD
Esmolol—Mental disorder—Sorafenib—thyroid cancer	0.00475	0.0048	CcSEcCtD
Esmolol—Erythema—Sorafenib—thyroid cancer	0.00472	0.00477	CcSEcCtD
Esmolol—Dysgeusia—Sorafenib—thyroid cancer	0.00462	0.00467	CcSEcCtD
Esmolol—Extravasation—Epirubicin—thyroid cancer	0.00457	0.00462	CcSEcCtD
Esmolol—Rigors—Doxorubicin—thyroid cancer	0.00452	0.00457	CcSEcCtD
Esmolol—Body temperature increased—Vandetanib—thyroid cancer	0.00452	0.00456	CcSEcCtD
Esmolol—Skin discolouration—Epirubicin—thyroid cancer	0.00442	0.00446	CcSEcCtD
Esmolol—Ventricular extrasystoles—Epirubicin—thyroid cancer	0.00442	0.00446	CcSEcCtD
Esmolol—Thinking abnormal—Epirubicin—thyroid cancer	0.00436	0.0044	CcSEcCtD
Esmolol—Oliguria—Epirubicin—thyroid cancer	0.00433	0.00437	CcSEcCtD
Esmolol—Angioedema—Sorafenib—thyroid cancer	0.00431	0.00435	CcSEcCtD
Esmolol—Syncope—Sorafenib—thyroid cancer	0.00423	0.00427	CcSEcCtD
Esmolol—Extravasation—Doxorubicin—thyroid cancer	0.00423	0.00427	CcSEcCtD
Esmolol—Loss of consciousness—Sorafenib—thyroid cancer	0.00415	0.00419	CcSEcCtD
Esmolol—Atrioventricular block—Epirubicin—thyroid cancer	0.00411	0.00415	CcSEcCtD
Esmolol—Inflammation—Epirubicin—thyroid cancer	0.00411	0.00415	CcSEcCtD
Esmolol—Asthenia—Vandetanib—thyroid cancer	0.0041	0.00414	CcSEcCtD
Esmolol—Skin discolouration—Doxorubicin—thyroid cancer	0.00409	0.00413	CcSEcCtD
Esmolol—Ventricular extrasystoles—Doxorubicin—thyroid cancer	0.00409	0.00413	CcSEcCtD
Esmolol—Pruritus—Vandetanib—thyroid cancer	0.00404	0.00408	CcSEcCtD
Esmolol—Thinking abnormal—Doxorubicin—thyroid cancer	0.00403	0.00407	CcSEcCtD
Esmolol—Oliguria—Doxorubicin—thyroid cancer	0.00401	0.00405	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00399	0.00403	CcSEcCtD
Esmolol—Ibuprofen—PPARG—thyroid cancer	0.00397	0.422	CrCbGaD
Esmolol—Dry mouth—Sorafenib—thyroid cancer	0.00393	0.00397	CcSEcCtD
Esmolol—Skin exfoliation—Epirubicin—thyroid cancer	0.00381	0.00385	CcSEcCtD
Esmolol—Atrioventricular block—Doxorubicin—thyroid cancer	0.00381	0.00384	CcSEcCtD
Esmolol—Inflammation—Doxorubicin—thyroid cancer	0.00381	0.00384	CcSEcCtD
Esmolol—Shock—Sorafenib—thyroid cancer	0.00379	0.00383	CcSEcCtD
Esmolol—Nervous system disorder—Sorafenib—thyroid cancer	0.00378	0.00381	CcSEcCtD
Esmolol—Dizziness—Vandetanib—thyroid cancer	0.00378	0.00381	CcSEcCtD
Esmolol—Chlorphenesin—PTGS2—thyroid cancer	0.00376	0.399	CrCbGaD
Esmolol—Neuropathy—Epirubicin—thyroid cancer	0.00375	0.00378	CcSEcCtD
Esmolol—Skin disorder—Sorafenib—thyroid cancer	0.00374	0.00378	CcSEcCtD
Esmolol—Anorexia—Sorafenib—thyroid cancer	0.00367	0.00371	CcSEcCtD
Esmolol—Vomiting—Vandetanib—thyroid cancer	0.00363	0.00367	CcSEcCtD
Esmolol—Ecchymosis—Epirubicin—thyroid cancer	0.00361	0.00364	CcSEcCtD
Esmolol—Headache—Vandetanib—thyroid cancer	0.00358	0.00361	CcSEcCtD
Esmolol—Pulmonary oedema—Epirubicin—thyroid cancer	0.00355	0.00359	CcSEcCtD
Esmolol—Skin exfoliation—Doxorubicin—thyroid cancer	0.00353	0.00356	CcSEcCtD
Esmolol—Abnormal vision—Epirubicin—thyroid cancer	0.00348	0.00351	CcSEcCtD
Esmolol—Neuropathy—Doxorubicin—thyroid cancer	0.00347	0.0035	CcSEcCtD
Esmolol—Mental disability—Epirubicin—thyroid cancer	0.00346	0.0035	CcSEcCtD
Esmolol—Dyspnoea—Sorafenib—thyroid cancer	0.00343	0.00347	CcSEcCtD
Esmolol—Nausea—Vandetanib—thyroid cancer	0.00339	0.00342	CcSEcCtD
Esmolol—Dyspepsia—Sorafenib—thyroid cancer	0.00339	0.00342	CcSEcCtD
Esmolol—Decreased appetite—Sorafenib—thyroid cancer	0.00335	0.00338	CcSEcCtD
Esmolol—Thrombophlebitis—Epirubicin—thyroid cancer	0.00335	0.00338	CcSEcCtD
Esmolol—Ecchymosis—Doxorubicin—thyroid cancer	0.00334	0.00337	CcSEcCtD
Esmolol—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00333	0.00336	CcSEcCtD
Esmolol—Fatigue—Sorafenib—thyroid cancer	0.00332	0.00335	CcSEcCtD
Esmolol—Constipation—Sorafenib—thyroid cancer	0.00329	0.00333	CcSEcCtD
Esmolol—Pain—Sorafenib—thyroid cancer	0.00329	0.00333	CcSEcCtD
Esmolol—Pulmonary oedema—Doxorubicin—thyroid cancer	0.00329	0.00332	CcSEcCtD
Esmolol—Abnormal vision—Doxorubicin—thyroid cancer	0.00322	0.00325	CcSEcCtD
Esmolol—Mental disability—Doxorubicin—thyroid cancer	0.0032	0.00323	CcSEcCtD
Esmolol—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00319	0.00322	CcSEcCtD
Esmolol—Thrombophlebitis—Doxorubicin—thyroid cancer	0.0031	0.00313	CcSEcCtD
Esmolol—Urticaria—Sorafenib—thyroid cancer	0.00306	0.00309	CcSEcCtD
Esmolol—Body temperature increased—Sorafenib—thyroid cancer	0.00305	0.00307	CcSEcCtD
Esmolol—Dermatitis bullous—Epirubicin—thyroid cancer	0.00303	0.00306	CcSEcCtD
Esmolol—Cardiac failure—Epirubicin—thyroid cancer	0.00297	0.003	CcSEcCtD
Esmolol—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00296	0.00298	CcSEcCtD
Esmolol—Dermatitis bullous—Doxorubicin—thyroid cancer	0.0028	0.00283	CcSEcCtD
Esmolol—Asthenia—Sorafenib—thyroid cancer	0.00276	0.00279	CcSEcCtD
Esmolol—Cardiac arrest—Epirubicin—thyroid cancer	0.00275	0.00278	CcSEcCtD
Esmolol—Cardiac failure—Doxorubicin—thyroid cancer	0.00275	0.00277	CcSEcCtD
Esmolol—Pruritus—Sorafenib—thyroid cancer	0.00273	0.00275	CcSEcCtD
Esmolol—Nasopharyngitis—Epirubicin—thyroid cancer	0.00259	0.00262	CcSEcCtD
Esmolol—Cardiac arrest—Doxorubicin—thyroid cancer	0.00255	0.00257	CcSEcCtD
Esmolol—Dizziness—Sorafenib—thyroid cancer	0.00255	0.00257	CcSEcCtD
Esmolol—Vomiting—Sorafenib—thyroid cancer	0.00245	0.00247	CcSEcCtD
Esmolol—Angina pectoris—Epirubicin—thyroid cancer	0.00244	0.00246	CcSEcCtD
Esmolol—Headache—Sorafenib—thyroid cancer	0.00241	0.00244	CcSEcCtD
Esmolol—Nasopharyngitis—Doxorubicin—thyroid cancer	0.0024	0.00242	CcSEcCtD
Esmolol—Dysuria—Epirubicin—thyroid cancer	0.00234	0.00236	CcSEcCtD
Esmolol—Nausea—Sorafenib—thyroid cancer	0.00229	0.00231	CcSEcCtD
Esmolol—Angina pectoris—Doxorubicin—thyroid cancer	0.00226	0.00228	CcSEcCtD
Esmolol—Drowsiness—Epirubicin—thyroid cancer	0.00223	0.00225	CcSEcCtD
Esmolol—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00219	0.00221	CcSEcCtD
Esmolol—Dysuria—Doxorubicin—thyroid cancer	0.00217	0.00219	CcSEcCtD
Esmolol—Drowsiness—Doxorubicin—thyroid cancer	0.00207	0.00209	CcSEcCtD
Esmolol—Bradycardia—Epirubicin—thyroid cancer	0.00204	0.00206	CcSEcCtD
Esmolol—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00202	0.00204	CcSEcCtD
Esmolol—Rhinitis—Epirubicin—thyroid cancer	0.00201	0.00203	CcSEcCtD
Esmolol—Pharyngitis—Epirubicin—thyroid cancer	0.00199	0.00201	CcSEcCtD
Esmolol—Urinary tract disorder—Epirubicin—thyroid cancer	0.00198	0.002	CcSEcCtD
Esmolol—Urethral disorder—Epirubicin—thyroid cancer	0.00196	0.00198	CcSEcCtD
Esmolol—Visual impairment—Epirubicin—thyroid cancer	0.00193	0.00195	CcSEcCtD
Esmolol—Bradycardia—Doxorubicin—thyroid cancer	0.00189	0.00191	CcSEcCtD
Esmolol—Flushing—Epirubicin—thyroid cancer	0.00186	0.00188	CcSEcCtD
Esmolol—Cardiac disorder—Epirubicin—thyroid cancer	0.00186	0.00188	CcSEcCtD
Esmolol—Rhinitis—Doxorubicin—thyroid cancer	0.00186	0.00188	CcSEcCtD
Esmolol—Pharyngitis—Doxorubicin—thyroid cancer	0.00184	0.00186	CcSEcCtD
Esmolol—Urinary tract disorder—Doxorubicin—thyroid cancer	0.00183	0.00185	CcSEcCtD
Esmolol—Angiopathy—Epirubicin—thyroid cancer	0.00182	0.00184	CcSEcCtD
Esmolol—Urethral disorder—Doxorubicin—thyroid cancer	0.00182	0.00184	CcSEcCtD
Esmolol—Chills—Epirubicin—thyroid cancer	0.0018	0.00182	CcSEcCtD
Esmolol—Visual impairment—Doxorubicin—thyroid cancer	0.00179	0.0018	CcSEcCtD
Esmolol—Mental disorder—Epirubicin—thyroid cancer	0.00176	0.00177	CcSEcCtD
Esmolol—Erythema—Epirubicin—thyroid cancer	0.00174	0.00176	CcSEcCtD
Esmolol—Flushing—Doxorubicin—thyroid cancer	0.00172	0.00174	CcSEcCtD
Esmolol—Cardiac disorder—Doxorubicin—thyroid cancer	0.00172	0.00174	CcSEcCtD
Esmolol—Dysgeusia—Epirubicin—thyroid cancer	0.00171	0.00172	CcSEcCtD
Esmolol—Angiopathy—Doxorubicin—thyroid cancer	0.00168	0.0017	CcSEcCtD
Esmolol—Ibuprofen—PTGS2—thyroid cancer	0.00168	0.178	CrCbGaD
Esmolol—Chills—Doxorubicin—thyroid cancer	0.00166	0.00168	CcSEcCtD
Esmolol—Mental disorder—Doxorubicin—thyroid cancer	0.00162	0.00164	CcSEcCtD
Esmolol—Erythema—Doxorubicin—thyroid cancer	0.00161	0.00163	CcSEcCtD
Esmolol—Agitation—Epirubicin—thyroid cancer	0.0016	0.00162	CcSEcCtD
Esmolol—Dysgeusia—Doxorubicin—thyroid cancer	0.00158	0.0016	CcSEcCtD
Esmolol—Syncope—Epirubicin—thyroid cancer	0.00156	0.00158	CcSEcCtD
Esmolol—Loss of consciousness—Epirubicin—thyroid cancer	0.00153	0.00155	CcSEcCtD
Esmolol—Convulsion—Epirubicin—thyroid cancer	0.00151	0.00153	CcSEcCtD
Esmolol—Chest pain—Epirubicin—thyroid cancer	0.00149	0.0015	CcSEcCtD
Esmolol—Agitation—Doxorubicin—thyroid cancer	0.00148	0.0015	CcSEcCtD
Esmolol—Anxiety—Epirubicin—thyroid cancer	0.00148	0.00149	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00148	0.00149	CcSEcCtD
Esmolol—Dry mouth—Epirubicin—thyroid cancer	0.00145	0.00147	CcSEcCtD
Esmolol—Syncope—Doxorubicin—thyroid cancer	0.00145	0.00146	CcSEcCtD
Esmolol—Confusional state—Epirubicin—thyroid cancer	0.00144	0.00145	CcSEcCtD
Esmolol—Oedema—Epirubicin—thyroid cancer	0.00142	0.00144	CcSEcCtD
Esmolol—Loss of consciousness—Doxorubicin—thyroid cancer	0.00142	0.00143	CcSEcCtD
Esmolol—Shock—Epirubicin—thyroid cancer	0.0014	0.00141	CcSEcCtD
Esmolol—Convulsion—Doxorubicin—thyroid cancer	0.0014	0.00141	CcSEcCtD
Esmolol—Nervous system disorder—Epirubicin—thyroid cancer	0.0014	0.00141	CcSEcCtD
Esmolol—Skin disorder—Epirubicin—thyroid cancer	0.00138	0.0014	CcSEcCtD
Esmolol—Hyperhidrosis—Epirubicin—thyroid cancer	0.00138	0.00139	CcSEcCtD
Esmolol—Chest pain—Doxorubicin—thyroid cancer	0.00137	0.00139	CcSEcCtD
Esmolol—Anxiety—Doxorubicin—thyroid cancer	0.00137	0.00138	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00136	0.00138	CcSEcCtD
Esmolol—Anorexia—Epirubicin—thyroid cancer	0.00136	0.00137	CcSEcCtD
Esmolol—Dry mouth—Doxorubicin—thyroid cancer	0.00134	0.00136	CcSEcCtD
Esmolol—Hypotension—Epirubicin—thyroid cancer	0.00133	0.00134	CcSEcCtD
Esmolol—Confusional state—Doxorubicin—thyroid cancer	0.00133	0.00134	CcSEcCtD
Esmolol—Oedema—Doxorubicin—thyroid cancer	0.00132	0.00133	CcSEcCtD
Esmolol—Shock—Doxorubicin—thyroid cancer	0.0013	0.00131	CcSEcCtD
Esmolol—Nervous system disorder—Doxorubicin—thyroid cancer	0.00129	0.0013	CcSEcCtD
Esmolol—Skin disorder—Doxorubicin—thyroid cancer	0.00128	0.00129	CcSEcCtD
Esmolol—Paraesthesia—Epirubicin—thyroid cancer	0.00128	0.00129	CcSEcCtD
Esmolol—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00127	0.00129	CcSEcCtD
Esmolol—Dyspnoea—Epirubicin—thyroid cancer	0.00127	0.00128	CcSEcCtD
Esmolol—Somnolence—Epirubicin—thyroid cancer	0.00127	0.00128	CcSEcCtD
Esmolol—Anorexia—Doxorubicin—thyroid cancer	0.00126	0.00127	CcSEcCtD
Esmolol—Dyspepsia—Epirubicin—thyroid cancer	0.00125	0.00127	CcSEcCtD
Esmolol—Decreased appetite—Epirubicin—thyroid cancer	0.00124	0.00125	CcSEcCtD
Esmolol—Hypotension—Doxorubicin—thyroid cancer	0.00123	0.00124	CcSEcCtD
Esmolol—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00123	0.00124	CcSEcCtD
Esmolol—Fatigue—Epirubicin—thyroid cancer	0.00123	0.00124	CcSEcCtD
Esmolol—Constipation—Epirubicin—thyroid cancer	0.00122	0.00123	CcSEcCtD
Esmolol—Pain—Epirubicin—thyroid cancer	0.00122	0.00123	CcSEcCtD
Esmolol—Paraesthesia—Doxorubicin—thyroid cancer	0.00118	0.00119	CcSEcCtD
Esmolol—Dyspnoea—Doxorubicin—thyroid cancer	0.00117	0.00119	CcSEcCtD
Esmolol—Feeling abnormal—Epirubicin—thyroid cancer	0.00117	0.00118	CcSEcCtD
Esmolol—Somnolence—Doxorubicin—thyroid cancer	0.00117	0.00118	CcSEcCtD
Esmolol—Dyspepsia—Doxorubicin—thyroid cancer	0.00116	0.00117	CcSEcCtD
Esmolol—Decreased appetite—Doxorubicin—thyroid cancer	0.00115	0.00116	CcSEcCtD
Esmolol—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00114	0.00115	CcSEcCtD
Esmolol—Fatigue—Doxorubicin—thyroid cancer	0.00114	0.00115	CcSEcCtD
Esmolol—Urticaria—Epirubicin—thyroid cancer	0.00113	0.00114	CcSEcCtD
Esmolol—Pain—Doxorubicin—thyroid cancer	0.00113	0.00114	CcSEcCtD
Esmolol—Constipation—Doxorubicin—thyroid cancer	0.00113	0.00114	CcSEcCtD
Esmolol—Body temperature increased—Epirubicin—thyroid cancer	0.00113	0.00114	CcSEcCtD
Esmolol—Feeling abnormal—Doxorubicin—thyroid cancer	0.00109	0.0011	CcSEcCtD
Esmolol—Urticaria—Doxorubicin—thyroid cancer	0.00105	0.00106	CcSEcCtD
Esmolol—Body temperature increased—Doxorubicin—thyroid cancer	0.00104	0.00105	CcSEcCtD
Esmolol—Asthenia—Epirubicin—thyroid cancer	0.00102	0.00103	CcSEcCtD
Esmolol—Pruritus—Epirubicin—thyroid cancer	0.00101	0.00102	CcSEcCtD
Esmolol—Asthenia—Doxorubicin—thyroid cancer	0.000945	0.000954	CcSEcCtD
Esmolol—Dizziness—Epirubicin—thyroid cancer	0.000942	0.000951	CcSEcCtD
Esmolol—Pruritus—Doxorubicin—thyroid cancer	0.000932	0.000941	CcSEcCtD
Esmolol—Vomiting—Epirubicin—thyroid cancer	0.000905	0.000914	CcSEcCtD
Esmolol—Headache—Epirubicin—thyroid cancer	0.000892	0.0009	CcSEcCtD
Esmolol—Dizziness—Doxorubicin—thyroid cancer	0.000871	0.00088	CcSEcCtD
Esmolol—Nausea—Epirubicin—thyroid cancer	0.000846	0.000854	CcSEcCtD
Esmolol—Vomiting—Doxorubicin—thyroid cancer	0.000838	0.000846	CcSEcCtD
Esmolol—Headache—Doxorubicin—thyroid cancer	0.000825	0.000833	CcSEcCtD
Esmolol—Nausea—Doxorubicin—thyroid cancer	0.000783	0.00079	CcSEcCtD
